2026-01-10 - Analysis Report
Okay, let's break down this Salesforce (CRM) analysis step-by-step.

**0. Report in English: Simple Numbers First, Then Analysis**

I will provide the numbers directly, followed by a brief analysis of what those numbers suggest.

**1. Return Rate Comparison: CRM vs. S&P 500 (VOO)**

*   **Company Overview:** Salesforce (CRM) is a leading provider of cloud-based software solutions for customer relationship management (CRM).
*   **CRM Cumulative Return:** -8.21%
*   **VOO (S&P 500) Cumulative Return:** 92.74%
*   **Divergence:**
    *   Max: 46.2
    *   Min: -111.1
    *   Current: -101.6
    *   Relative Divergence: 6.0

**Analysis:** CRM has significantly underperformed the S&P 500. The current divergence is quite negative, indicating a considerable difference in performance. The relative divergence of 6.0 suggests that the current divergence is close to the minimum divergence seen in the provided historical data.

**Alpha, Beta Analysis**

|            | CAGR     | MDD   | Alpha  | Beta | Cap(B) |
| :--------- | :------- | :---- | :----- | :--- | :----- |
| 2016-2018  | 21.0%    | 29.8% | 17.0%  | 1.4  | 130.1  |
| 2017-2019  | 15.0%    | 29.8% | -2.0%  | 1.4  | 154.5  |
| 2018-2020  | 9.0%     | 29.8% | -11.0% | 1.1  | 211.4  |
| 2019-2021  | 33.0%    | 21.2% | -10.0% | 1.1  | 241.4  |
| 2020-2022  | -73.0%   | 59.8% | -71.0% | 1.2  | 125.9  |
| 2021-2023  | -42.0%   | 59.8% | -43.0% | 1.4  | 249.9  |
| 2022-2024  | -37.0%   | 52.3% | -56.0% | 1.4  | 317.6  |
| 2023-2025  | 10.0%    | 32.1% | -52.0% | 1.2  | 251.6  |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate (CAGR) shows volatile performance, with significant positive growth in earlier periods and substantial losses in more recent periods (2020-2024).
*   **MDD:** The Maximum Drawdown (MDD) indicates the potential for significant losses, particularly in recent years.
*   **Alpha:**  Alpha is consistently negative in recent periods, demonstrating underperformance relative to the market benchmark.
*   **Beta:** Beta is consistently above 1, indicating that CRM's price is more volatile than the market.
*   **Cap(B):** Market capitalization has fluctuated significantly.

**2. Recent Stock Price Fluctuations**

*   **Close:** 260.53
*   **Last-market:** price: 259.94, previousClose: 260.53, change: -0.23
*   **5-day SMA:** 259.886
*   **20-day SMA:** 261.503
*   **60-day SMA:** 250.454

**Analysis:** The stock price is slightly below the 5-day and 20-day SMAs, but above the 60-day SMA. This suggests a potential short-term downward trend or consolidation, but an overall positive trend over the past two months.

**3. RSI, PPO, and Expected Return**

*   **MRI (Market Risk Indicator):** 0.7 (Medium Investment Recommended)
*   **RSI:** 52.86
*   **PPO:** -0.3055
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (1 shares - Safe - MRI:0.80) (Cash Ratio: 0% on 2025-12-04)
*   **Recent (20 days) relative divergence change:** -0.9 (단기하락, short-term decline)
*   **Last-market fluctuation change:** price': 259.94, 'previousClose': 260.53, 'change': -0.23 (relatively minor)
*   **Expected Return (%):** -749.7

**Analysis:**

*   The MRI suggests a medium level of investment risk.
*   The RSI is neutral (around 50), suggesting neither overbought nor oversold conditions.
*   The PPO being slightly negative indicates a slight downtrend.
*   The hybrid signal suggests a buy recommendation.
*   The recent negative divergence change confirms the short-term decline.
*   The extremely negative expected return is very concerning and strongly suggests caution.

**4. Recent News & Significant Events (Yahoo Finance)**

*   **[2026-01-09] Salesforce Plunges 20% in a Year: Is CRM Stock Still a Hold?** (Yahoo Finance) - *Indicates negative performance and questions about its investment status.*
*   **[2025-12-24] Salesforce Is Ready to Emerge an AI Winner. Buy the Stock.** (Barron's) - *Presents a bullish outlook, suggesting potential for AI-driven growth.*
*   **[2026-01-09] Jim Cramer Discusses Salesforce (CRM)'s Business** (Finviz) - *Suggests a need to understand the business fundamentals.*
*   **[2026-01-08] How To Earn 8.6% Yield While Waiting to Buy CRM 30% Cheaper** (Trefis) - *Implies that the stock might be overvalued and a better entry point might be lower.*
*   **[2025-12-24] Could This Be Your Chance To Buy Salesforce Stock Cheaply?** (Forbes) - *Asks if the current price represents a value opportunity.*
*   **[2026-01-07] Salesforce stock rises as tech steadies after soft jobs data; CRM investors eye Friday payrolls** (TechStock²) - *Highlights sensitivity to macroeconomic data.*

**Analysis:** The news is mixed. There are articles suggesting potential for AI-driven growth and value opportunities, but also concerns about recent performance and potential overvaluation. The sensitivity to jobs data suggests macroeconomic factors are important.

**4-2) Analyst Opinions**

*   **Consensus:** Buy
*   **Mean Rating:** 1.64 (~Buy)
*   **Opinions:** 53
*   **Target Price (avg/high/low):** 330.16 / 475.00 / 223.00
*   **Recent Rating Changes:** No specific recent rating changes provided.

**Analysis:**  Analysts, on average, have a "Buy" rating and a target price significantly higher than the current price. This indicates optimism about the future potential of the stock. However, the wide range in target prices (223 to 475) suggests considerable uncertainty among analysts.

**5. Recent Earnings Analysis**

| Date       | EPS  | Revenue    |
| :---------- | :---- | :---------- |
| 2025-12-04 | 2.2  | 10.26 B$ |
| 2025-09-04 | 1.97 | 10.24 B$ |
| 2025-05-29 | 1.61 | 9.83 B$  |
| 2024-12-04 | 1.6  | 9.44 B$  |
| 2025-12-04 | 1.6  | 9.44 B$  |

**Analysis:**  Both EPS and Revenue have been generally increasing, with a noticeable jump in EPS in the most recent quarter. This indicates positive earnings momentum.

**6. Financial Information: Revenue, Profitability, Capital, and ROE**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
| :------------ | :--------- | :-------------- |
| 2025-10-31 | $10.26B | 78.02%         |
| 2025-07-31 | $10.24B | 78.10%         |
| 2025-04-30 | $9.83B  | 76.96%         |
| 2025-01-31 | $9.99B  | 77.81%         |
| 2024-10-31 | $9.44B  | 77.71%         |

**Analysis:** Revenue has been consistently growing, and the profit margin is exceptionally high, indicating strong pricing power and efficient operations.

**Capital and Profitability:**

| Quarter      | Equity    | ROE     |
| :------------ | :--------- | :------- |
| 2025-10-31 | $60.02B | 3.48%  |
| 2025-07-31 | $61.33B | 3.08%  |
| 2025-04-30 | $60.67B | 2.54%  |
| 2025-01-31 | $61.17B | 2.79%  |
| 2024-10-31 | $58.52B | 2.61%  |

**Analysis:**  Equity has remained relatively stable, and ROE (Return on Equity) has been increasing, indicating improving profitability relative to the company's equity.

**7. Comprehensive Analysis (Summary)**

**Overall Assessment: Mixed Signals, Proceed with Caution**

The analysis presents a mixed picture for Salesforce (CRM).

**Positive Factors:**

*   **Strong Revenue and Profitability:** CRM demonstrates consistent revenue growth and extremely high profit margins.
*   **Increasing ROE:** Return on Equity is improving, indicating better profitability.
*   **Analyst Buy Rating:** The consensus analyst rating is a "Buy" with a significantly higher target price, reflecting potential upside.
*   **Recent EPS Beat:** Positive EPS growth in the most recent quarter.
*   **Potential AI-Driven Growth:** News articles highlight potential for growth in the AI space.

**Negative Factors:**

*   **Significant Underperformance vs. S&P 500:** CRM has significantly underperformed the market, reflected in a negative cumulative return and a large negative divergence.
*   **Negative Alpha and High Beta:** The stock has consistently underperformed its benchmark and is more volatile than the market.
*   **Mixed News Sentiment:** Recent news presents both positive (AI potential, value opportunities) and negative (poor recent performance, potential overvaluation) views.
*   **Extremely Negative Expected Return:** The -749.7% expected return is a *major* red flag. This may be an error in the provided data, or may need further investigation.
*   **Potential Overvaluation:** News suggests that the stock might be overvalued and a better entry point might be lower.

**Recommendation:**

Due to the conflicting signals, particularly the extremely negative expected return, a cautious approach is warranted. While strong fundamentals and analyst optimism exist, the underperformance, volatility, and questionable expected return raise concerns. It would be prudent to:

*   **Investigate the "Expected Return" figure:** This is the most critical point of concern and needs to be validated.
*   **Monitor Market Sentiment:** Closely watch news and analyst revisions.
*   **Consider a Smaller Position:** If pursuing an investment, consider a smaller allocation to manage the risk.
*   **Diversify:** Ensure a well-diversified portfolio to mitigate the impact of any single investment.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.